All In Biotech

Drug Trial Radar · NCT05975983

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Last checked: Nov 20, 2026Latest source record: Nov 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Feb 8, 2024

Primary completion

Feb 28, 2026

Study completion Feb 28, 2026

Sponsor

Sponsor type
Industry
First posted
Aug 4, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this revised Phase IIa study is to demonstrate safety of INS018\_055 over 12 weeks in adults with Idiopathic Pulmonary Fibrosis (IPF).

Conditions

  • Idiopathic Pulmonary Fibrosis (IPF)

Interventions

  • INS018_055Drug

    Pharmaceutical formulation: Tablet Mode of Administration: Oral

  • PlaceboDrug

    Pharmaceutical formulation: Tablet Mode of Administration: Oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of subjects who have at least 1 treatment-emergent adverse event (TEAE)Time frame: Day 1 (Visit 2) up to Week 12 (End of Treatment (EOT))

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama · Recruiting

  • HonorHealth Research Institute

    Scottsdale, Arizona · Recruiting

  • Keck School of Medicine of USC

    Los Angeles, California · Recruiting

  • Florida Lung Asthma and Sleep Specialist

    Celebration, Florida · Recruiting

  • Central Florida Pulmonary Group, P.A. (CFPG) - Downtown Orlando

    Orlando, Florida · Recruiting

  • Southeastern Research Center

    Winston-Salem, North Carolina · Recruiting

  • University of Oklahoma Health Sciences Center (OUHSC)

    Oklahoma City, Oklahoma · Recruiting

  • Temple University Hospital-Temple Lung Center

    Philadelphia, Pennsylvania · Recruiting

  • Bogan Sleep Consultants, LLC

    Columbia, South Carolina · Recruiting

  • University of Texas Southwestern Medical Center

    Dallas, Texas · Recruiting

  • Metroplex Pulmonary and Sleep Center

    McKinney, Texas · Recruiting

  • Research Centers of America

    McKinney, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.